Skip to content

Darunavir/ritonavir as effective in women as men

Early warning indicators for drug resistance in resource-limited settings piloted in Namibia

FTC therapy reduces risk of important resistance mutation

US CDC finds 19 percent HIV prevalence among MSM in 21-city survey

High long-term economic costs associated with late HIV diagnosis

HIV treatment is costly, especially for the sickest patients

5.25 million receiving ARVs by end of 2009

Treatment with tenofovir associated with more bone loss than abacavir, but long-term consequences unclear

Infectious and non-infectious lung disease risk increased for those with HIV

Mass rape and HIV in conflict-affected countries: despite relatively low incidence, researchers stress urgency of interventions for thousands of women in need

Detectable genital HIV shedding associated with cervical infections appears minimal among women taking ART

HIV - the recession bites

Don’t forget SP: testing untested children

JD and Max tell their stories

How HIV harms young brains

Symptoms still common in patients with HIV, and associated with poor adherence and risky sex

Individual risk factors crucial in determining a patient's risk of heart attack if taking abacavir